Skip to main content

stock

RXST · RxSight, Inc.

What RxSight, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live RXST price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on RXST.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Ophthalmic Goods (SIC 3851)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
41,593,256 as of 2026-07-31 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
-45.5%
Net
-6.6%

Returns

ROE
-3.0%
ROA
-2.3%

Health

Current ratio
4.1x
Debt/equity
—

Deep value

NCAV
$238.04M
NCAV per share
$5.72
Price/NCAV
Locked
NNWC
-$43.56M
NNWC per share
-$1.05
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$27.24M—-$13.77M-$12.10M
10-Q filed 2026-08-05
2026-03-31$30.89M$23.50M-$17.83M-$15.88M
10-Q filed 2026-08-05
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$32.61M$25.26M-$11.34M$29.79M
DEF 14A filed 2026-04-28
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$30.34M$24.23M-$12.18M-$9.82M
10-Q filed 2025-11-05
2025-06-30$33.64M$25.19M-$14.00M-$11.79M
10-Q filed 2026-08-05
Assembled from more than one filing; the filing above is only the newest of them.
2025-03-31$37.90M$28.33M-$10.67M-$8.19M
10-Q filed 2026-08-05
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$40.21M$28.79M-$8.63M$21.52M
DEF 14A filed 2026-04-28
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$35.31M$25.22M-$9.23M-$6.34M
10-Q filed 2025-11-05
Assets
$352.70M
Equity
$263.34M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$134.48M-$48.19M-$39-$19.34M
2024-12-31$139.93M-$36.86M-$28-$22.39M
2023-12-31$89.08M-$50.09M-$49-$46.41M
2022-12-31$49.01M-$63.32M-$67-$61.24M
2021-12-31$22.59M-$52.79M-$48.69M-$46.65M
2020-12-31$14.68M-$35.41M$27.57M-$37.74M

Company filings

events

  • Results

    Results
    Aug 58-K
  • Executive or director change, Regulation FD disclosure

    Executive or director changeRegulation FD disclosure
    Jul 158-K
  • Material agreement, Regulation FD disclosure

    Material agreementRegulation FD disclosure
    Jul 68-K
  • Results

    Results
    Jul 68-K
  • Shareholder vote results

    Shareholder vote results
    Jun 168-K
  • Results

    Results
    May 68-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • Kurtz Ronald M MD

    Chief Medical Officer

    Sale$35,496

    Sep 2, 9:35 PM ET

  • Wilterding Mark

    Chief Financial Officer

    Sale$54,044

    Sep 2, 9:35 PM ET

  • Goldshleger Ilya

    Chief Operating Officer

    Sale$14,205

    Sep 2, 9:34 PM ET

  • Weinberg Eric

    See remarks

    Sale$14,205

    Sep 2, 9:33 PM ET

All insider trades for RXST

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

  • Point72

    Period Tue 30 Jun 2026

    0.0%Added

All funds

News

Stories that named RXST, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about RXST.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about RXST.

nakagai

Signals on RXST come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the RXST board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

RxSight, Inc. (RXST): SEC filings, financials and insider trades · Nakagai